Erawat Pharma Limited, a active public limited company, was established on 01 March 1993 in Indore, Madhya Pradesh, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U02423MP1993PLC007538. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹6.95 Cr and a paid-up capital of ₹6.75 Cr.
Formerly known as Erawat Pharma Private Limited. It upholds a compliant status. Employing 175 professional, Its leadership includes Amit Jain (Whole-Time Director), Vasant Raj Solanki (Director), Devindar Singh Sodhi (Director). Past directors included Vinod Gokulchand Kataria, Raj Kirtani, Amit Jain. It holds ₹50.00 Cr open charges and ₹29.78 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12C, F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, 452010.
U02423MP1993PLC007538
007538
01 March 1993
₹6.95 Cr
₹6.75 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Erawat Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Jain | Whole-Time Director | 01 Oct 2018 | Current |
| Vasant Raj Solanki | Director | 16 Aug 1994 | Current |
| Devindar Singh Sodhi | Director | 30 Apr 1997 | Current |
| Hemchandra Jain | Managing Director | 01 Mar 1993 | Current |
| Abhijeet Jain | Whole-Time Director | 01 Oct 2018 | Current |
| Abhishek Jain | Whole-Time Director | 11 Jul 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jul 2015 | Past |
| Pramod Abcsdd | Director | 18 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Company Secretary | 01 Apr 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Erawat Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.01% increase. The company also saw a substantial fall in profitability, with a 13.38% decrease in profit. The company's net worth Soared by an impressive increase of 32.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Erawat Pharma had a promoter holding of 80.70% and a public holding of 19.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹499,951,115.00
₹297,750,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2024 | Sidbi | ₹8.18 M | Open |
| 26 Feb 2024 | Others | ₹8.91 M | Open |
| 22 Nov 2023 | Sidbi | ₹1.28 Cr | Open |
| 13 Apr 2023 | Others | ₹8.24 Cr | Open |
| 21 Oct 2022 | Others | ₹6.00 Cr | Open |
Explore comprehensive loan charge details -
Erawat Pharma has a workforce of 175 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Erawat Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erawat Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 0.82 Cr with Charge ID 101006106 was registered on 20 Nov 2024. was documented.
Erawat Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others of Rs. 0.89 Cr registered on 26 Feb 2024 with Charge ID 100886118 was modified on 09 Aug 2024. was completed.
Progress on A charge with Others of Rs. 6.00 Cr registered on 21 Oct 2022 with Charge ID 100628027 was modified on 09 Aug 2024. was documented.
Progress on A charge with Others of Rs. 0.69 Cr registered on 21 Oct 2022 with Charge ID 100627269 was modified on 09 Aug 2024. was documented.
A charge with Others of Rs. 0.43 Cr registered on 21 Oct 2022 with Charge ID 100627262 was modified on 09 Aug 2024. was recorded as a recent event.
The CIN of Erawat Pharma Limited is U02423MP1993PLC007538.
Erawat Pharma Limited is headquartered at 12C, F A Scheme No. 94 Ring Road, Indore, Madhya Pradesh, 452010.
Erawat Pharma Limited was incorporated on 01 March 1993.
The current directors of Erawat Pharma Limited are
The primary industry of Erawat Pharma Limited is Manufacturing.
Erawat Pharma Limited is unlisted.
The authorized capital of Erawat Pharma Limited is ₹6.95 Cr, and the paid-up capital is ₹6.75 Cr.
The compliance status of Erawat Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX